广发中证香港创新药ETF发起式联接(QDII)C(019671)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
9,627.37 |
14,070.69 |
17,310.76 |
| 存出保证金 |
15,428.96 |
4,458.34 |
1,142.75 |
| 交易性金融资产 |
109,185,717.05 |
47,694,823.68 |
34,061,231.40 |
| 其中：股票投资 |
- |
- |
- |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
712,771.49 |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
1,725,667.42 |
221,143.82 |
409,216.84 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
120,568,852.28 |
51,985,675.74 |
37,493,862.62 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
1,312,252.49 |
299.34 |
- |
| 应付赎回款 |
2,266,880.65 |
651,987.61 |
1,395,456.73 |
| 应付管理人报酬 |
3,234.59 |
1,348.27 |
1,154.12 |
| 应付托管费 |
646.92 |
269.64 |
230.81 |
| 应付销售服务费 |
17,351.28 |
6,901.72 |
4,841.04 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
19,053.65 |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
135,041.50 |
32,571.13 |
15,501.14 |
| 负债合计 |
3,754,461.08 |
693,377.71 |
1,417,183.84 |
| 所有者权益 |
| 实收基金 |
147,914,168.86 |
76,464,897.41 |
40,342,148.76 |
| 未分配利润 |
-31,099,777.66 |
-25,172,599.38 |
-4,265,469.98 |
| 所有者权益合计 |
116,814,391.20 |
51,292,298.03 |
36,076,678.78 |
| 负债及所有者权益总计 |
120,568,852.28 |
51,985,675.74 |
37,493,862.62 |
微信公众号
证券之星APP
基本资料
